People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant
India is looking forward to WHO's nod for vaccine manufactured by Bharat Biotech
Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, SII has also sought protection against liabilities
Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease
According to a study, there were 275 cases of myocarditis identified between December 2020, when the vaccination drive began, and May 2021, including 148 cases within a month after vaccination.
Only around 3 per cent of the population has been inoculated till now. The Indian government is expected to grant foreign vaccine makers Pfizer and Moderna indemnity against legal proceedings
Earlier, vaccines that had completed clinical studies outside the country were required to carry out "bridging trials" or limited clinical trials on the Indian population
The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech
The SAD chief accused Prime Minister Narendra Modi and CM Singh of having failed to fulfil their duty to provide vaccines to people.
Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic
Pfizer's indemnity request is also being looked into by the government
Companies, including Moderna and Pfizer, have said they will deal only with the Centre and not state governments
Covaxin production by Bharat Biotech is being increased: Paul
Delhi Chief Minister Arvind Kejriwal on Thursday sought procurement of Pfizer Covid-19 vaccine as soon as possible to inoculate children
Cypriot health authorities on Wednesday advised people aged under 50 to use the Pfizer/BioNTech or Moderna vaccines that are based on the newer, mRNA technology
Suitable for 12 yrs and above, Pfizer tells govt
Here are the best of Business Standard's opinion pieces for Tuesday
Union govt in direct talks with firms but order book full for now
Business Standard brings you the top news of the evening
'Allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidance,' says the US drugmaker to Punjab govt